Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Odonate Therapeutics, Inc. (ODT)
Sector: Healthcare; Industry: Biotechnology

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer; and CONTESSA 2 and CONTESSA TRIO, which is in Phase II clinical study for central nervous system metastases and various cancer treatments.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-12-29 Johnson Craig A Director Buy 3,000 $17.00 $51,000 No
2020-12-30 Boxer Capital, LLC 10%-Owner, Director Buy 400,000 $17.16 $6,863,428 No
2020-12-30 Davis Aaron I. 10%-Owner, Director Buy 400,000 $17.16 $6,863,428 No
2020-12-23 TANG KEVIN C Chief Executive Officer Buy 275,784 $15.16 $4,181,208 No
2020-09-29 Davis Aaron I. 10%-Owner, Director Buy 215,200 $13.63 $2,932,156 No
2020-09-29 Boxer Capital, LLC 10%-Owner, Director Buy 215,200 $13.63 $2,932,156 No
2020-09-29 TANG KEVIN C Chief Executive Officer Buy 110,882 $13.13 $1,456,408 No
2020-09-09 Davis Aaron I. 10%-Owner, Director Buy 225,000 $14.99 $3,371,631 No
2020-09-09 Boxer Capital, LLC 10%-Owner, Director Buy 225,000 $14.99 $3,371,631 No
2020-08-28 Boxer Capital, LLC 10%-Owner, Director Buy 1,403,509 $14.25 $20,000,003 No
2020-08-28 Davis Aaron I. 10%-Owner, Director Buy 1,403,509 $14.25 $20,000,003 No
2020-08-28 TANG KEVIN C Chief Executive Officer Buy 1,052,631 $14.25 $14,999,992 No
2019-06-26 Boxer Capital, LLC 10%-Owner Buy 384,615 $26.00 $9,999,990 No
2019-06-26 Vacirca Jeff L Director Buy 19,231 $26.00 $500,006 No
2019-06-26 TANG KEVIN C Chief Executive Officer Buy 769,231 $26.00 $20,000,006 No
2019-06-18 TANG KEVIN C Chief Executive Officer Buy 50,000 $26.15 $1,307,546 No
2019-06-07 TANG KEVIN C Chief Executive Officer Buy 76,308 $27.36 $2,087,457 No
2019-06-05 TANG KEVIN C Chief Executive Officer Buy 93,692 $24.92 $2,335,217 No
2019-03-08 TANG KEVIN C Chief Executive Officer Buy 140,000 $18.26 $2,556,316 No
2019-03-04 Vacirca Jeff L Director Buy 3,000 $17.00 $51,000 No
2018-12-31 TANG KEVIN C Chief Executive Officer Buy 63,700 $13.11 $835,107 No
2018-12-26 Davis Aaron I. 10%-Owner, Director Buy 125,000 $13.27 $1,658,830 No
2018-12-26 Boxer Capital, LLC 10%-Owner, Director Buy 125,000 $13.27 $1,658,830 No
2018-12-26 TANG KEVIN C Chief Executive Officer Buy 60,000 $12.60 $755,857 No
2018-12-18 TANG KEVIN C Chief Executive Officer Buy 40,000 $14.67 $586,639 No
2018-12-12 TANG KEVIN C Chief Executive Officer Buy 20,000 $15.60 $312,073 No
2018-12-07 TANG KEVIN C Chief Executive Officer Buy 20,000 $14.79 $295,864 No
2018-11-27 TANG KEVIN C Chief Executive Officer Buy 3,063 $15.64 $47,912 No
2018-11-26 TANG KEVIN C Chief Executive Officer Buy 16,937 $15.29 $259,017 No
2018-11-01 TANG KEVIN C Chief Executive Officer Buy 10,000 $14.87 $148,727 No

Insider Smart

Enphase Energy, Inc (ENPH) - Watch for CEO Kothandaraman Badrinarayanan and CFO Branderiz Eric, their trading have a good pattern you can't miss, very well timed buy low and sell high.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.